This advisory will showcase some of the best stocks that Cabot has to offer. You will build a diversified portfolio of the best growth, momentum, value, international, and dividend stocks all for a very affordable price.
Tim Lutts is not only the Chief Analyst of Cabot Stock of the Month, he is also Cabot’s Chief Investment Strategist. This puts Tim in a unique position to select the most attractive stock from a wide variety of Cabot advisories.
Cabot Stock of the Month recommends one stock each month from five other Cabot advisories, including value stocks, growth stocks, momentum stocks, dividend stocks and international stocks, depending on what appears to be the most promising stock for the current market conditions. The advisory does not present a model portfolio—i.e., there's no cash position, weightings, etc.; however, all recommendations are followed up weekly with buy, hold and eventually sell ratings. The performance shown is the average gain of Cabot Stock of the Month's current holdings, as of 6/2915.
105% in Stryker
78% in Melco Crown Entertainment
72% in Express Scripts
69% in Salix Pharmaceuticals
Try Cabot Stock of the Month risk-free for 12 months.
Cabot Stock of the Month is an affordable, easy-to-follow advisory to the best growth, momentum, value, international and dividend stocks.
What our Customers say about Cabot Stock of the Month
"Tim, I am writing to say thank you! You brought my attention to Middleby last July. At that time, I bought in at the share price of 73.59. I sold my shares on Thursday May 14 at 109.72 the recommend minimum sell price that Roy had set. I realized a return of 49% on my money in 9.5 months! I appreciate all the work you and the team does at Cabot. I am thankful to have found your company."
J. Cook, Arcadia, California
This is exactly the kind of information I need. Please keep it up.
T. Picking, Pueblo, Colorado
Hi Mr. Lutts, Thanks for a winner in Stryker (SYK), like others who watch your newsletters I had purchased Stryker on Cabot’s recommendation a while back and last night it hit my sell limit at 81. Nice profit for me and it will pay for more of your newsletters! I have told several friends and hopefully they will become subscribers too. Thanks again for your advice and sharing your knowledge.
Rob Rochelle, Charlotte, North Carolina
Are you ready to get started with your risk-free trial subscription?